Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice.
BACKGROUND
Perioperative management of therapy with anticoagulants or platelet inhibitors for patients having cutaneous surgery presents dilemmas for dermatologic surgeons.


OBJECTIVE
To outline the current spectrum of practice for perioperative management.


METHODS
Questionnaires were mailed to 504 dermatologic surgeons. Data included use of warfarin, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs) perioperatively and involvement of other physicians in making management decisions.


RESULTS
Of the responding physicians, 83% routinely ask primary physicians or cardiologists for recommendations about perioperative management, 80% discontinue warfarin therapy perioperatively at least some of the time, 26% always discontinue aspirin therapy, 38% manage aspirin and NSAIDs in the same manner, and 53% withhold therapy with NSAIDs for less time than with aspirin.


CONCLUSIONS
Dermatologic surgeons use various perioperative management strategies. Despite no published evidence of increased hemorrhagic risk with anticoagulant or platelet inhibitor therapy during cutaneous surgery, many physicians discontinue therapy perioperatively.
Kovich
Olympia
O
Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Otley
Clark C
CC
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage; D062109:Dermatologic Surgical Procedures; D006801:Humans; D007400:Interprofessional Relations; D019990:Perioperative Care; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011795:Surveys and Questionnaires; D014859:Warfarin / Q000008:administration & dosage
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin